Probi celebrates 35 years of biotic science
It has over 300 publications on LP299V and launches postbiotic Rham271h with new partnerships.
See the latest news and media coverage for Probi. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer and manufacturer of clinically proven biotics
probi.comLast updated
In short: Probi joined the Symrise Group in 2025, leading to its delisting from Nasdaq Stockholm and integration into a new Care & Wellness Division.
It has over 300 publications on LP299V and launches postbiotic Rham271h with new partnerships.
It introduces the first postbiotic solution at Vitafoods Europe, offering immune support, stability, and formulation flexibility for functional foods. CEO Anita Johansen highlights its benefits.
The study shows LP299V® reduces kidney stress and gut inflammation biomarkers in endurance runners. It supports performance and recovery.
They showcase product launches including Hibicyan™ for vascular health and Rham271h™ postbiotic. Probi introduces sports nutrition solutions. Event occurs May 5–7, 2026 in Barcelona.
Symrise and Probi are set to feature several innovations at Vitafoods Europe 2025 in Barcelona, Spain (May 20–22). The companies will highlight several new innovations...
THE WHAT? Symrise has acquired approximately 90.2 percent of the shares in Probi. The flavors and fragrances firm announced a public offer and has acquired...
Net sales in Q2 amounted to SEK 178.9 m, corresponding to an increase of 25% compared to last year (23% adjusted for currency effects). The...
Probi and Perrigo have signed an “extensive” pan-European agreement enabling the companies to expand probiotic digestive and immune health concepts into 14 European countries, according...
Track Probi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.